This study explored the response to very low doses of recombinant human growth hormone (rhGH) in aging individuals. It found that despite the natural decline in Insulin-Like Growth Factor I (IGF-I) levels associated with aging, the peripheral sensitivity to rhGH remained intact. The study demonstrated that even at low doses,
